by Jason Fairchild | May 6, 2024
Leveraging the large patient population with cystic fibrosis (CF) cared for by the MGH CF Center, the goal of this research program is to improve our understanding and treatment of CF-related diabetes (CFRD). CF is a life-shortening disease that causes progressive...
by Jason Fairchild | May 6, 2024
The Powe clinical research group focuses on studying diabetes and the glucose metabolism of women who are pregnant or recently postpartum. Studies aim to improve our understanding of metabolic disease affecting this population by focusing on endocrine physiology and...
by Jason Fairchild | May 6, 2024
Dr. Nathan directs the MGH Diabetes Center, which provides clinical care to patients with diabetes and focuses on the development and evaluation of innovative therapies for type 1 and type 2 diabetes and their complications. Dr. Nathan and the Diabetes Center have...
by Jason Fairchild | May 6, 2024
The Mostoslavsky laboratory is interested in understanding the influence of chromatin on nuclear processes (gene transcription, DNA recombination and DNA repair) and the relationship between chromatin dynamics and the metabolic adaptation of cells. One of our...
by Jason Fairchild | May 6, 2024
The research program is aimed at utilizing the new tools of genomics and computational biology to understand mitochondrial biology and metabolism. We are particularly interested in the rare mitochondrial disorders – collectively the largest class of inborn errors of...
